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Abstract
Background: The safety of healthcare workers exposed to
formaldehyde remains a great matter of concern for healthcare
management units. This work aimed at describing the results of a
combined monitoring approach (environmental and biological) to
manage occupational exposure to formaldehyde in a hospital set-
ting. 
Design and Methods: Environmental monitoring of working
spaces and biological monitoring of urinary formaldehyde in 16
exposed healthcare workers of the Anatomic Pathology Unit of a
University Hospital in Southern Italy was performed on a four-
year timescale (2016-2019). 
Results: Values of aero-dispersed formaldehyde identified
were on average low; although workers’ urinary formaldehyde
levels were also minimal, the statistical analysis highlighted a
slight weekly accumulation. 
Conclusions: Our data confirm that both environmental and
biological monitoring are important to identify risk situations, in
particular when values of hazardous compounds are below the
accepted occupational exposure levels. 
Introduction
Formaldehyde (FA) is a widespread chemical substance hav-
ing formula HCHO, commercially available as an aqueous solu-
tion known as formalin, containing 30-50% FA with methanol as
a stabilizer to prevent its polymerization. Formaldehyde solution
is a clear colourless liquid with a pungent and irritating smell1 and
is mainly used in the canning industry, leather tanning, embalm-
ing, fabric manufacture, and as a biocide in the food industry.2
Formaldehyde is endogenously produced in living organisms as a
by-product of serine, glycine, methionine, and various other
amino acids metabolism. Endogenous levels of metabolic FA pro-
duction range from 3 to 12 ng/g of tissue;3 plasmatic concentration
of FA in humans is estimated to be ca. 2.5 ppm. Exogenous FA
does not accumulate in the body and is rapidly eliminated from
human plasma; a biological half-life of this molecule of only 1-1.5
min seems to be responsible for preventing FA systemic distribu-
tion in the human body.4,5 Indeed, no increase in FA blood concen-
tration has been observed in either humans, rats, or monkeys after
acute exposure at concentrations of 1.9 ppm (2.3 mg/m3), 6 ppm
(7.2 mg/m3), and 14.4 ppm (17.3 mg/m3) of gaseous FA, respec-
tively. This can be explained with both formaldehyde main depo-
sition in the respiratory tract and rapid metabolism.6
Possible ways of exposure to exogenous FA are ingestion,
inhalation, skin absorption, and blood exchange. Once absorbed,
FA is quickly metabolized by almost all body tissues and convert-
ed into a non-toxic chemical compound called formate, which is
then expelled with urine. Formaldehyde can also be converted into
carbon dioxide and exhaled out of the body via pulmonary expira-
tion (Figure 1). 
Despite the rapid elimination from the human body, the expo-
sure to exogenous FA sources, both indoors and outdoors, poses a
significant threat to human health, and the interest in this topic has
been boosted by the current legal statement that has labeled FA as
a “Carcinogen for man” - category 1.7,8
Workers employed in industries producing FA or FA-contain-
ing substances, along with laboratory technicians and certain
healthcare professionals, may be exposed to higher levels of this
molecule compared to the general public. These workers can suf-
fer from harmful effects from breathing FA gas or vapor or by
absorbing liquid containing FA through the skin. The site of direct
contact (eyes, nose, throat, and skin), in fact, quickly reacts with
FA, which can destroy protective skin oils causing dryness, flak-
ing, and dermatitis. High levels of FA (5-30 ppm) can severely
irritate the lungs, causing chest pain and breathing problems.
Humans perceive FA smell at a concentration of about 0.5-1.0
ppm, followed by sensory irritation (>2.0 ppm) of nose, throat,
and eyes, with eye irritation accepted as the most sensitive end-
point. Both hepatotoxicity and neurotoxicity have also been con-
sidered as potential effects of formaldehyde exposure.9,10
In hospital units, FA in aqueous solution, or formalin, is used
for collection and transport of tissues derived from surgical inter-
ventions and biopsies in operating rooms and biopsy sampling
clinics (endoscopy, radiology, etc.) and as a fixative in pathologi-
Significance for public health
Health workers' regular exposure to formaldehyde may be responsible for long-term health issues; unfortunately, threshold limits of this compound are not har-
monized between different government agencies. The combination of environmental and biological monitoring thus becomes an invaluable tool to preserve











cal anatomy for its unique properties of preserving cell and tissue
morphology. National and international guidelines recommend the
use of buffered formalin for histological, immunohistochemical,
and molecular (gene mutation) examinations. In addition, all vali-
dated protocols related to histochemical, immunohistochemical,
and molecular investigations are currently standardized on forma-
lin-fixed tissues.11 Thus, monitoring environmental FA levels to
which health workers are exposed through the use of an efficient
methodology to measure biological levels of FA is of crucial
importance to prevent organism overload and potential multi-organ
damage. 
The main goal of this work was to describe operational strate-
gies aimed at reducing the risk related to FA exposure in hospital
settings by using an approach combining Environmental and
Biological Monitoring. FA measurements based on this combined
method were performed on a four-year timescale at a University
Hospital in Southern Italy, where environmental and urinary FA
levels of 16 employees working at the Anatomic Pathology Unit
were evaluated. 
                                                                                                    
Design and Methods
Building and facilities
The Anatomic Pathology Unit is located on the ground floor of
the clinical building and has five rooms for specimen treatment, a
corridor, and physicians’ rooms. In all rooms, a ventilation system
is installed, consisting of down flown ventilation with conditioned
air flowing into the room from the ceiling and extraction units in
the walls; openable windows to the outside of the building are pre-
sent. Formaldehyde is mainly used in a 23 m2 room, equipped with
a chemical hood and an aspirated cupboard for the storage of
anatomical samples. 
At the beginning of our monitoring activity (2016), sampling
concerned all department rooms to evaluate FA dispersion also in
locations not directly affected by the processing of histological
samples. In the second, third, and fourth monitoring campaigns
(2017, 2018, 2019) only the processing room was analyzed.
Biological monitoring of urinary formaldehyde
Workers’ urinary FA was measured using High Performance
Liquid Chromatography (HPLC) coupled with a UV-Visible detec-
tor (HPLC-UV). A CE-IVD (European Certification - in vitro
Diagnostics) kit provided by the “Eureka Lab Division” was used.
According to the manufacturer, urinary samples were derivatized
with a chemical reagent supplied with the kit and incubated at
70°C for 15 min. Then, five-hundred microliters of HPLC-grade
water were added to the sample and 50 μl of the resulting mixture
was directly injected into the HPLC system.
The chromatographic separation was achieved by RP-HPLC,
performed on a Waters 1525 Model Binary Pump System equipped
with a multi λ Fluorescence detector (Model 2475), a Photodiode
Array detector (Model 2998), and an Autosampler (Model 2707)
(Waters, Milford, MA, USA). Samples in the autosampler were at
RT and a column oven was used to maintain column temperature
at 30°C. Breeze software 2.0 (Waters) was used for peak analysis,
integration, and to calculate the linear regression of the calibration
curve. Chromatographic analysis was carried out on a Poroshell
120 EC-C18 (50×4.6 mm, 2.7 μm) column (Agilent). The mobile
phase was included in the commercial kit. The separation was
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Figure 1. Formaldehyde pathway and metabolism.










achieved by isocratic elution with a flow rate of 1.2 ml min-1.
Analytes were revealed with a UV detector set at λ= 385 nm.
Environmental monitoring of formaldehyde
Formaldehyde environmental monitoring was performed on
selected fixed locations by both: 
1) active sampling using chemo-adsorbent tubes (following
NIOSH 2016 method), with a properly calibrated pump, provided
by Aquaria srl (Lacchiarella, MI, Italy), and whose flow was set to
a constant value of 1L/min throughout the sampling period. The
sampling flow rate was checked continuously by a fluxometer.12,13
Four samples per working day and three measurements for each
sample were analyzed and mean values were reported. The sam-
pling procedure requires a known volume of sample air (from 1 to
15 litres) to be passed through an acidified silica gel coated with
2,4-dinitrophenylhydrazine (DNPH). Formaldehyde reacts with
the DNPH producing the corresponding hydrazone. After the sam-
pling phase, tubes were closed with caps, transported, and stored in
glass containers in refrigerated systems maintained at a controlled
temperature. 
2) diffusive (passive) sampling, to evaluate average concentra-
tion values (TLV-TWA 8 h per working day), by exposing diffusive
samplers (RING devices provided by Aquaria srl) containing a sil-
ica gel cartridge coated with 2,4-dinitrophenylhydrazine (DNPH)
in one selected location. This method is indicated for long-term
monitoring.14-18 Three measurements were realized for each deter-
mination and the average value was reported. At the end of the
sampling phase, tubes were closed with the appropriate caps and
stored in glass containers in refrigerated systems maintained at a
controlled temperature. The mass concentration C(μg/m3) of pas-
sive samplers was calculated with the manufacturer’s uptake rate
of 92 ml/min, and using the following formula:
C(μg/m3) =   mass (μg) /10 -6 x P(ml/min) x time (min)
This equation can be directly derived from Fick’s first law con-
sidering that the mass of the analyte is sorbed by diffusion,16 time
represents the time of exposition of the sampler and P, the diffusive
uptake rate, is dependent only on the diffusion coefficient of the
given analyte and on the geometry of the diffusive sampler used.
The limit of detection (LOD) of this methodology was three-
times the standard deviation of the blank values (as reported in EN
13528-2) and accuracy was calculated as the 2σ deviation of the
absolute differences of the individual sample values compared to
the mean in triplicate samples.19
Formaldehyde sampled with both active and passive samplers
was detected according to the method described by NIOSH 2016,20
which involves an organic extraction with acetonitrile and subse-
quent analysis by HPLC. Analyses were performed on an HPLC
instrument with a PDA detector set at 385 nm supplied by Waters®
Corporation and an Ascentis® C18 analytical column (4.6 mm x
150 mm, 3 µm); chromatographic elution conditions consisted in a
mobile phase composed of 45% acetonitrile/55% water (v/v) and a
flow rate of 1.0 ml/min. For data analysis, Breeze® 2.0 software,
supplied by Waters®, was used. Extraction was performed by
adding 3 ml of acetonitrile to the vial.
Analytic grade acetonitrile and 99.9% pure formaldehyde-2,4-
dinitrophenylhydrazone (FA-2,4-DNPH) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). For calibration, a known
amount of FA-2,4-DNPH was weighed and diluted in acetonitrile;
from this stock, dilutions in acetonitrile were prepared for calibra-
tion in a range of 0.23 to 37 μg per sample.
RING diffusion samplers and tubes for active sampling were
provided by Aquaria® srl. Water and acetonitrile (ACN) were pur-
chased from Romil® (Waterbeach, Cambridge, UK) and were all
HPLC grade. 
Statistical analyses
Data were expressed as means ±SD per year, as median and
range of values (min - max); comparisons between the different
years of collection were analyzed and comparisons of the values of
the different work shifts were analyzed. These analyses were per-
formed considering the differences between FA levels measured
during working days (intra- and inter-day backlog) and basal val-
ues (start of weekly work shift).
Results
Environmental monitoring
To maintain a safe and healthy workplace for employees work-
ing with hazardous chemicals such as FA, it is important to mini-
mize exposure to this compound. To this purpose, the maximum air
concentration of the chemicals that may still be considered safe has
been defined as time-weighted averages measured over 8 h (TWA)
and short-term exposure limits (STEL) for a 15 min period (TLV-
Ceiling). However, these occupational exposure limits (OELs) can
be set at World level, at European level, at national level or by
companies themselves and, therefore, regulations for setting OELs
may deeply vary. Moreover, OEL can be estimated by different
methods, which may result in a variety of OELs. Table 1 reports
the main Threshold Limit Values for FA proposed by different
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Table 1. Threshold limit values for formaldehyde provided by main government agencies.
Organization/legal of countries                                                                                            Type                       Concentration (ppm)
Occupational Safety and Health Administration (OSHA-USA)                                                                             TWA                                                  0.75
                                                                                                                                                                                            STEL                                                   2.0
American conference of Governmental Industrial Hygienists (ACGIH-USA)                                                   TWA                                                   0.1
                                                                                                                                                                                            STEL                                                  0.3 
National Institute for Occupational Safety and Health (NIOSH)                                                                        TWA                                                 0.016 
                                                                                                                                                                                            STEL                                                  0.1 
World Health Organization (WHO)                                                                                                                            STEL                                                 0.08 
Scientific Committee on Occupational Exposure Limits UE (SCOEL)                                                             TWA                                                   0.3
                                                                                                                                                                                            STEL                                                  0.6 
TWA, time-weighted averages measured over 8 h; STEL, short-term exposure limits.











It is important to underline that these limits do not constitute a
clear dividing point between non-dangerous and harmful concen-
tration, but they only indicate the concentrations of the airborne
substances to which it is believed that most workers can remain
exposed for eight-hours daily, forty hours a week, forty-eight
weeks a year, without suffering of adverse health effects. 
The environmental monitoring campaign in the Anatomic
Pathology Unit was aimed at evaluating the amount of airborne FA
in the various environments, and the ability of FA to diffuse
between adjacent rooms. Twenty sampling areas were selected in
the structure to evaluate the concentration of FA and identify the
possible diffusive path of FA in the environments adjacent to the
histological sample processing room. In Table 2 the results of four
monitoring campaigns at the Anatomic Pathology Unit of the
Hospital are reported. During the first campaign (2016), we ran-
domized the sampler location to identify the sampling sites that
could be representative of the general pollution conditions, where-
as sampling was focused on a fixed location during the next cam-
paigns (2017-2018-2019). Sampling was performed by both pas-
sive and active methods, as described in the Materials and Methods
Section to verify compliance with both TWA and STEL limits.
As expected, the active sampling method returned a higher
concentration than the passive method. However, all active and
passive measurements showed compliance with the OSHA and
ACGIH exposure limits, but not always with the lowest NIOSH
REL. Only a few active measurements exceeded NIOSH STEL,
mainly in correspondence with the sampling site located near the
open trash bin next to the fume hood. 
These results were in agreement with the inaccurate and erro-
neous workers’ practice to throw in the open bin gloves and paper
towels used to clean FA contaminated surfaces, thus leading to the
evaporation of residual formaldehyde in the environment.
Moreover, since it is well known that environmental factors
such as temperature and relative humidity may influence the per-
formances of passive samplers, we always checked these parame-
ters using a calibrated instrument for measuring environmental
parameters; values are reported in Table 1 and show minimal vari-
ations for each sampling period. In particular, the temperature was
in the range of 25-28°C and the relative humidity was in the range
of 38-52%. In these conditions, no adverse effect on recovery is
expected. 
Noteworthy, the percentage of non-compliance, calculated as
the number of measurements above the OEL, decreases from the
first to the last monitoring campaign from 50% to 7% for the active
measurements and from 12.2% to 0% for the passive one. This
marked improvement in environmental conditions mainly depend-
ed on the employees who, despite no structural or technical
changes in the work environment had been realized, had perceived
the importance of their actions in limiting the spread of formalde-
hyde, and devoted greater attention to the actions they carried on
daily.
Biological monitoring 
Each biological monitoring campaign included three with-
drawal times, more specifically on Monday morning at the begin-
ning of the weekly shift (T0), Monday evening at the end of the
daily shift (T1), and Friday evening at the end of the weekly shift.
This timing allowed evaluating both the intra-day exposure and the
weekly backlog (inter-day exposure). By analysing urinary FA
concentrations at the beginning of the working week, it was also
possible to evaluate whether any abnormal level of FA was related
to an occupational rather than an accidental exposure, for example
during the weekend. Biological monitoring started in Fall 2016 and
was repeated every six months, in parallel with environmental
monitoring. Urine samples were collected, labeled, and stored at -
20°C until analysis.
A statistical comparison of the values obtained in the four
years analysed (Figure 2), shows that the highest average value
was measured in 2018 (0.75 mg/L). The analysis of variance
(ANOVA) shows that in 2018 the values deviate less from the
mean value. Medians reflect this trend, with higher values in 2018
and lower in the second half of 2017.
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Figure 2. Average values of the three sampling times obtained for
each monitoring campaign.
Table 2. Formaldehyde concentration (ppm) detected in the Anatomic Pathology Unit of the University Hospital "San Giovanni di Dio
e Ruggi d 'Aragona" in Salerno (Italy) in four years.
Year              RH                 Temperature         Sampling method          n. samples          Averages                 Range            Non-compliance 
                    (%)                       (°C)                 (active/passive)                                           (ppm)                    (ppm)                       (%)
2016                   46±6                           25.7±1.0                              Passive                                    15                           0.0098                      0.0033-0.0400                         12.2
                                                                                                               Active                                      24                           0.0790                      0.0220-0.1390                         50.0
2017                   42±4                           25.2±0,8                              Passive                                    30                           0.0013                      0.0004-0.0050                            0
                                                                                                               Active                                      48                           0.0430                      0.0290-0.1587                         22.2
2018                   45±7                           25.8±2.0                              Passive                                    27                           0.0006                    0.00014-0.00105                          0
                                                                                                               Active                                      56                           0.0380                      0.0134-0.1250                         10.0
2019                   44±7                           27.8±2.0                              Passive                                    20                           0.0005                    0.00018-0.00098                          0
                                                                                                               Active                                      52                           0.0280                      0.0060-0.1050                          7.0
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Table 3 shows the average values obtained in each single mon-
itoring campaign. The reference value used to identify potential
risk for the workers is, according to the guidelines of the Italian
Association of Industrial Hygienists (AIDII)
(https://www.aidii.it/), 5.6 mg/L. As evident from Figure 2 and
Table 3, values were always far below the accepted threshold
value. However, it is worth noting that in 2016 and the first cam-
paign of 2017, the average of the values recorded on Friday
evening was higher than that of Monday end shift, thus suggesting
the tendency, albeit minimal, to a weekly stack.
In the second half of 2017 and in 2018, the three sampling
times report comparable values; this can be attributed to exposure
of workers to outside FA sources, not imputable to hospital
workspace, or, likely, to a subjective endogenous level of FA.
An analysis focusing on single workers’ values trend, mea-
sured over the four years, has been shown in Figure 3. In 2016,
61.5% of the values, measured on Friday at the end of the working
shift (T2), increased compared to the values measured on Monday
evening at the end of the working shift (T1), while the intra-day
measurements of the first working day (T0 vs T1) highlighted an
increase in FA values in 69.2% of workers. In 2017, the trend was
similar. In 2018, we observed an increase in T1 vs T2 for 50% of
workers, with values more than doubled in 18.7% of cases. In the
T0 vs T1 measurements, on the other hand, an increase in FA val-
ues was found in only 25% of workers.
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Table 3. Formaldehyde values measured in each biological monitoring campaign for workers in the Anatomic Pathology Unit of the
University Hospital "San Giovanni di Dio e Ruggi d 'Aragona" in Salerno (Italy). Values expressed in mg/l.
Year                            Mean ±SD                                        Median                  Range (min-max)
2016                                          0.39±0.23                                                            0.33                                                                      0.03                                                  0.93
2017/1                                       0.34±0.25                                                            0.27                                                                      0.06                                                  0.99
2017/2                                       0.22±0.14                                                            0.22                                                                      0.03                                                  0.80
2018/1                                       0.52±0.17                                                            0.48                                                                      0.22                                                  1.04
2018/2                                       0.65±0.39                                                            0.56                                                                      0.13                                                  1.89
2019/1                                       0,52±0,23                                                            0.45                                                                      0.06                                                  0.91
2019/2                                       0.41±0.32                                                            0.38                                                                      0.04                                                  1.31










Starting January 2016, FA re-classification as a “carcinogenic
substance” has urged employers to find solutions to limit workers’
exposure to this harmful compound. Doubts and fears among
workers due to the risk associated with FA professional exposure,
are rightful. Short-term health effects are variable depending on
the subject’s sensitivity to the compound and include irritative
pathologies mainly affecting upper and lower airways.21
In Italy, a maximum exposure limit for FA in working and liv-
ing environments was initially set, as early as 1983, at a concentra-
tion of 0.1 ppm (124 μg/m3).22 European Union has definitively
classified FA as a carcinogenic substance (category 1B) with the
EU regulation No. 895/2014, concerning the registration, evalua-
tion, authorization, and restriction of chemical substances
(REACH). Italy has fully adopted this classification and included
it into Legislative Decree 81/08, which specifies the employer’s
obligations to replace the carcinogenic compound, when possible,
and to reduce the exposure to the lowest technically possible level.
According to these guidelines, a risk assessment must be reconsid-
ered every three years, or in case of modifications of the workflow
routine. It is important to underline that the regulation foresees that
the employer also measures the presence of carcinogens or muta-
gens to verify the efficacy of the measures adopted.23
This work aimed at providing an example of a combined
approach of environmental and biological monitoring carried out
at a University Hospital setting in Southern Italy. Values of aero-
dispersed FA, resulting from environmental analyses, were on
average very low, except for some environments, in which the con-
centrations slightly overcame the limit values established by
NIOSH (TLV = 0.1 ppm), with a maximum value of 0.16 ppm
(macroscopic room, where bioptic samples were analysed).
Accordingly, analyses performed on workers’ urinary samples
showed low values of FA, far from accepted TLV. 
Statistical analysis of biological samples suggested a potential
FA weekly accumulation. Although a different number of samples
was analysed in each campaign, due to the turnover of department
personnel, it is worth underlining that in 2018-2019 we noticed a
lowering, albeit minimal, of FA accumulation levels between the
beginning and the end of the working week. 
However, it should be emphasized that the measurement of uri-
nary formaldehyde levels in the long-term has severe limits, due to
its very short half-life; therefore, other markers should be investi-
gated to evaluate biological long-term backlog. Furthermore,
AIDII guidelines consider as professional exposure limit values
that are compatible with manufacturing companies, but not with
environments such as hospitals, where the use of FA is used at
much lower concentrations, but still potentially harmful. This led
us to use the limit suggested by NIOSH, as it is the lowest.
Nevertheless, our results clearly show that the concomitant analy-
sis of air quality and actual workers’ exposure is a key tool to allow
optimization of work safety procedures, which must become rou-
tinely in hospitals. Combining environmental and biological mon-
itoring is necessary to understand the state of workplaces, the effi-
cacy of individual protection disposables, and the air filtering sys-
tem. This is also important to assess the adherence of workers to
good laboratory practices and preserve their health status. References
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